Judith M. Ertle - Publications

Hepatic improvement within 27 days of avenciguat treatment in Child-Pugh A cirrhosis detected by an oral cholate challenge test.

Journal: Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society

Published: March 19, 2024

Variability of transient elastography-based spleen stiffness performed at 100 Hz.

Journal: European radiology experimental

Published: July 11, 2023

Safety and pharmacokinetics of BI 685509, a soluble guanylyl cyclase activator, in patients with cirrhosis: A randomized Phase Ib study.

Journal: Hepatology communications

Published: March 03, 2023

The rationale and study design of two phase II trials examining the effects of BI 685,509, a soluble guanylyl cyclase activator, on clinically significant portal hypertension in patients with compensated cirrhosis.

Journal: Trials

Published: December 10, 2022

A randomised Phase IIa trial of amine oxidase copper-containing 3 (AOC3) inhibitor BI 1467335 in adults with non-alcoholic steatohepatitis.

Journal: Nature communications

Published: November 21, 2022

Evaluation of emerging NASH therapies: the impact of treatment efficacy profiles on long-term health outcomes.

Journal: Journal of comparative effectiveness research

Published: November 01, 2022

Impaired lymphocyte function in patients with hepatic malignancies after selective internal radiotherapy.

Journal: Cancer immunology, immunotherapy : CII

Published: June 29, 2017

The GALAD scoring algorithm based on AFP, AFP-L3, and DCP significantly improves detection of BCLC early stage hepatocellular carcinoma.

Journal: Zeitschrift fur Gastroenterologie

Published: December 10, 2016

Selective internal radiation therapy of hepatic tumors: procedural implications of a patent hepatic falciform artery.

Journal: SpringerPlus

Published: July 10, 2014

Selective internal radiation therapy of hepatic tumours: is coiling of the gastroduodenal artery always beneficial?

Journal: Clinical radiology

Published: September 26, 2013

A new model to estimate prognosis in patients with hepatocellular carcinoma after Yttrium-90 radioembolization.

Journal: PloS one

Published: July 11, 2013

Choi criteria are superior in evaluating tumor response in patients treated with transarterial radioembolization for hepatocellular carcinoma.

Journal: Oncology letters

Published: May 30, 2013